| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Mar―07 |
Assessing severity of COVID-19 and the development of multi system inflammatory syndrome in children (MIS-C) in pediatric patients with atopic disease |
Natalie E. Rudsenske, Jessica B. Perkins |
| 2 |
[GO] |
2023―Dec―28 |
An 82-year-old man with new skin lesions after COVID-19 vaccination |
Patricia J. Choi, Merritt L. Fajt |
| 3 |
[GO] |
2023―Nov―03 |
Impact of COVID-19 measures on exacerbation rates and healthcare visits in US asthma patients |
Helene Karcher, Matthias Schoenberger, Tejaswini Rayban, Caoimhe Kelly, Andrew Heaney, Alexander Mackay |
| 4 |
[GO] |
2023―Sep―06 |
The COVID-19 impact on severe uncontrolled asthma costs and biologic use |
Najm S. Khan, Elizabeth Rubin, Bernard McKenna, Bernard L. Palowitch, Frank Sonnenberg, Judith Argon, Reynold A. Panettieri |
| 5 |
[GO] |
2023―Sep―06 |
Symptom flares after COVID-19 infection versus vaccination among youth with PANS/PANDAS |
Maria D. LaRusso, Cesar E. Abadia |
| 6 |
[GO] |
2023―Sep―06 |
Diagnosis of eosinophilic esophagitis in patients with dysphagia during the Coronavirus Disease 2019 (COVID-19) pandemic |
Jennifer Brennan, Kelsey Yamada, Taha Al-Shaikhly, Gisoo Ghaffari |
| 7 |
[GO] |
2023―Jul―22 |
Evaluation of disease control after SARS-CoV-2 infection or vaccination in patients with NSAID-exacerbated airway disease |
Melek Cihanbeylerden, Ozge Can Bostan, Gulseren Tuncay, Cagla Safak, Ebru Damadoglu, Gul Karakaya, Ali Fuat Kalyoncu |
| 8 |
[GO] |
2023―May―27 |
The third pandemic: The respiratory syncytial virus landscape and specific considerations for the allergist/immunologist |
Lawrence D. Frenkel, Sananda Gaur, Joseph A. Bellanti |
| 9 |
[GO] |
2023―Mar―06 |
Hereditary Angioedema: Impact of COVID-19 pandemic stress upon disease related morbidity and well-being |
Sandra C. Christiansen, Camila Lopes Veronez, Tukisa D. Smith, Marc A. Riedl, Bruce L. Zuraw |
| 10 |
[GO] |
2022―Dec―28 |
Salivary and serum IgA and IgG after COVID-19 and after immunization with COVID-19 vaccines |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
| 11 |
[GO] |
2022―Nov―06 |
Positive perception of COVID-19 vaccination in HAE: No significant impact of vaccination on disease course |
Nida Oztop, Semra Demir, Ilkim Deniz Toprak, Derya Unal, Aslı Gelincik |
| 12 |
[GO] |
2022―Nov―06 |
Pearls and pitfalls: Adverse cutaneous reactions after COVID-19 vaccination |
Mechelle Miller, Michael Tracey, Meagan Simpson, Cecilia Mikita |
| 13 |
[GO] |
2022―Sep―06 |
Asthma biomarkers and COVID-19 continue to dominate current medical issues |
Joseph A. Bellanti, Russell A. Settipane |
| 14 |
[GO] |
2022―Sep―06 |
Cat allergy in children and the effect of the COVID-19 pandemic |
Sule Buyuk Yaytokgil, Azize Pinar Metbulut, Tayfur Giniş, Muge Toyran, Ersoy Civelek, Emine Dibek Misirlioğlu |
| 15 |
[GO] |
2022―Sep―06 |
Efficacy and safety of an e-consult program for COVID-19 vaccine allergy concerns |
Timothy Kaddis, Shyam Joshi, Karen M. Anstey |
| 16 |
[GO] |
2022―Sep―06 |
Salivary and serum IgA and IgG responses to SARS-CoV-2-spike protein following SARS-CoV-2 infection and after immunization with COVID-19 vaccines |
Dongmei Li, Richard Calderone, Talal M. Nsouli, Elizabeth Reznikov, Joseph A. Bellanti |
| 17 |
[GO] |
2022―Sep―06 |
The long COVID syndrome: A conundrum for the allergist/immunologist |
Joseph A. Bellanti |
| 18 |
[GO] |
2022―May―07 |
COVID-19 pandemic impact on telehealth use and perceptions for atopic and respiratory disease: Survey results |
Don A. Bukstein, Jacqueline Eghrari-Sabet, Mary Hart, Tanisha Hill, Purvi Parikh, Tonya A. Winders |
| 19 |
[GO] |
2022―May―07 |
Long COVID: A proposed hypothesis-driven model of viral persistence for the pathophysiology of the syndrome |
Danilo Buonsenso, Michele Piazza, Attilio L. Boner, Joseph A. Bellanti |
| 20 |
[GO] |
2022―Mar―23 |
Clinical effects of intranasal corticosteroids on nasal symptoms in subjects with chronic rhinitis during COVID-19 |
Can Tuzer, Pelin Karadag, Ozan Yegit, Deniz Eyice, Nida Oztop, Ali Can, Semra Demir, Raif Coskun, Derya Erdogdu Unal, Muge Olgac, Suna Buyukozturk, Bahattin Colakoglu, Aslı Gelincik |
| 21 |
[GO] |
2022―Jan―05 |
Monitored COVID-19 mRNA vaccine second doses for people with adverse reactions after the first dose |
Megan C. Gallagher, Sarah Haessler, Elizabeth Pecoy-Whitcomb, Jonathan Bayuk |
| 22 |
[GO] |
2022―Jan―05 |
Global perceptions of the current and future impacts of COVID-19 on hereditary angioedema management |
Vesna Grivcheva-Panovska, Timothy J. Craig, Hilary Longhurst, Noémi Bara, Irina Panovska |
| 23 |
[GO] |
2022―Jan―05 |
Delayed systemic urticarial reactions following mRNA COVID-19 vaccination |
Mitchell M. Pitlick, Avni Y. Joshi, Alexei Gonzalez-Estrada, Sergio E. Chiarella |
| 24 |
[GO] |
2022―Jan―05 |
Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-2 |
Eli Magen, Avi Yakov, Ilan Green, Ariel Israel, Shlomo Vinker, Eugene Merzon |
| 25 |
[GO] |
2021―Dec―06 |
COVID-19 and hereditary angioedema: Incidence, outcomes, and mechanistic implications |
Camila Lopes Veronez, Sandra C. Christiansen, Tukisa D. Smith, Marc A. Riedl, Bruce L. Zuraw |
| 26 |
[GO] |
2021―Dec―06 |
Does aeroallergen sensitivity and allergic rhinitis in children cause milder COVID-19 infection? |
Emine Vezir, Mina Hizal, Burcu Cura Yayla, Kubra Aykac, Arzu Yilmaz, Gamze Kaya, Pembe Derin Oygar, Yasemin Ozsurekci, Mehmet Ceyhan |
| 27 |
[GO] |
2021―Dec―06 |
COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol |
Gayatri B. Patel, Krishan D. Chhiba, Michael M. Chen, Amina Guo, Melissa M. Watts, Jane Cullen, Bruce S. Bochner, Leslie C. Grammer, Paul A. Greenberger, Carol A. Saltoun, Whitney W. Stevens, Fei Li Kuang, Anju T. Peters |
| 28 |
[GO] |
2021―Dec―06 |
The immunologic response to severe acute respiratory syndrome coronavirus 2 |
Nicole K. Le, Kelsey Kaman, Hannah C. Martin, Jyotsna Mullur, Kristen K. Stenehjem, Lokesh Coomar, Burak Bahar, Mudit Dutta, Ricardo Izurieta, Joel P. Brooks |
| 29 |
[GO] |
2021―Dec―06 |
SARS-CoV-2 infection and the human immune system: A continuing journey of discovery |
Joseph A. Bellanti, Russell A. Settipane |
| 30 |
[GO] |
2021―Sep―06 |
Effect of COVID-19 on hereditary angioedema activity and quality of life |
Ozge Can Bostan, Gulseren Tuncay, Ebru Damadoglu, Gul Karakaya, Ali Fuat Kalyoncu |
| 31 |
[GO] |
2021―Sep―06 |
Sustained decrease in pediatric asthma emergency visits during the first year of the COVID-19 pandemic |
Samantha Arsenault, Jacob Hoofman, Pavadee Poowuttikul, Elizabeth Secord |
| 32 |
[GO] |
2021―Sep―06 |
The global burden of vaccine-preventable infectious diseases in children less than 5 years of age: Implications for COVID-19 vaccination. How can we do better? |
Lawrence D. Frenkel |
| 33 |
[GO] |
2021―Sep―06 |
Vaccine preventable diseases, vaccine hesitancy, and COVID-19: A role for the allergist/immunologist |
Joseph A. Bellanti, Russell A. Settipane |
| 34 |
[GO] |
2021―Aug―10 |
COVID-19 vaccines and vaccine hesitancy: Role of the allergist/immunologist in promotion of vaccine acceptance |
Joseph A. Bellanti |
| 35 |
[GO] |
2021―Jun―30 |
Outcomes among patients with COVID-19 and asthma: A systematic review and meta-analysis |
Andrea N. Sitek, Justine M. Ade, Sergio E. Chiarella, Rohit D. Divekar, Mitchell M. Pitlick, Vivek N. Iyer, Zhen Wang, Avni Y. Joshi |
| 36 |
[GO] |
2021―Jun―30 |
Psychological burden of COVID-19 on mild and moderate chronic spontaneous urticaria |
Sengul Beyaz, Semra Demir, Nida Oztop, Pelin Karadag, Raif Coskun, Bahauddin Colakoglu, Suna Buyukozturk, Asli Gelincik |
| 37 |
[GO] |
2021―Jun―30 |
COVID-19: A continuing challenge for the allergist/immunologist |
Joseph A. Bellanti, Russell A. Settipane |
| 38 |
[GO] |
2021―May―25 |
Shifts in allergy practice in a COVID-19 world: Implications of pre-COVID-19 national health care provider and patient surveys of treatments for nasal allergies |
Tonya Winders, Lawrence DuBuske, Don A. Bukstein, Eli O. Meltzer, Dana Wallace, Karen Rance |
| 39 |
[GO] |
2021―May―13 |
COVID-19 in Italian children and adolescents: The role of allergy and asthma |
Maria Angela Tosca, Amelia Licari, Gian Luigi Marseglia, Giorgio Ciprandi |
| 40 |
[GO] |
2021―May―13 |
Is nutraceutical supplementation appropriate for COVID-19 management? |
Michele Piazza, Attilio L. Boner, Sandro Girotto, Ercole Concia, Joseph A. Bellanti |
| 41 |
[GO] |
2021―May―13 |
Coronavirus disease 2019, allergic diseases, and allergen immunotherapy: Possible favorable mechanisms of interaction |
Désirée E. Larenas-Linnemann, José A. Ortega-Martell, María V. Blandón-Vijil, Noel Rodríguez-Pérez, Jorge A. Luna-Pech, Alan Estrada-Cardona, Alfredo Arias-Cruz, Blanca E. Del Rio-Navarro, Elsy M. Navarrete Rodríguez, Cesar F. Pozo-Beltrán, Ernesto Onuma Takane, María I. Rojo-Gutiérrez, Francisco J. Espinosa-Rosales, Eric A. Martínez-Infante |
| 42 |
[GO] |
2021―Feb―04 |
COVID-19 in a patient with severe asthma using mepolizumab |
Kurtulus Aksu, Selma Yesilkaya, Musa Topel, Suleyman Turkyilmaz, Dilek Cuhadar Ercelebi, Ali Oncul, Ilkay Koca Kalkan, Hale Ates |
| 43 |
[GO] |
2021―Jan―06 |
COVID-19 in children: Pathogenesis and current status |
Lawrence D. Frenkel, Fernando Gomez, Joseph A. Bellanti |
| 44 |
[GO] |
2021―Jan―06 |
The challenge of COVID-19 that permeates the practice of allergy/immunology |
Joseph A. Bellanti, Russell A. Settipane |
| 45 |
[GO] |
2021―Jan―06 |
For the patient: COVID-19 vaccines and the public challenges and solutions |
|
| 46 |
[GO] |
2020―Dec―24 |
Considerations for asthma management and viral transmission in the era of COVID-19 |
Mitchell M. Pitlick, Avni Y. Joshi |
| 47 |
[GO] |
2020―Dec―24 |
The war on infectious diseases: COVID-19 vaccines and the public: Challenges and solutions |
Joseph A. Bellanti, Russell A. Settipane |
| 48 |
[GO] |
2020―Nov―04 |
COVID-19 in children: Pathogenesis and current status |
Lawrence Frenkel, Fernando Gomez, Joseph A Bellanti |
| 49 |
[GO] |
2020―Oct―28 |
The allergist/immunologist, the Janus gatekeeper of inflammation, COVID-19 and beyond |
Joseph A. Bellanti, Russell A. Settipane |
| 50 |
[GO] |
2020―Oct―28 |
Eosinopenia could be a relevant prognostic biomarker in patients with coronavirus disease 2019 |
Stefano Perlini, Giorgio Ciprandi, Riccardo Castagnoli, Amelia Licari, Gian Luigi Marseglia |
| 51 |
[GO] |
2020―Aug―15 |
The role of the allergist/immunologist in the COVID-19 pandemic: A Janus-faced presentation |
Joseph A Bellanti |
| 52 |
[GO] |
2020―Jul―01 |
COVID-19, allergic disease and asthma: Extraordinary challenges for the allergist/immunologist |
Joseph A. Bellanti, Russell A. Settipane |
| 53 |
[GO] |
2020―Jul―01 |
Successful treatment of coronavirus disease 2019 in a patient with asthma |
Avni Y. Joshi, Roshini M. Mullakary, Vivek N. Iyer |
